Biomarin Pharmaceutical Inc (BMRN)

06:30 AM

Is BioMarin Pharmaceutical Inc. a good long term investmentStrongest growth potential - PrintWeekIndia

06:30 AM

01:46 AM

What analysts say about BioMarin Pharmaceutical Inc. stockConsistently superior profits - PrintWeekIndia

01:46 AM

Jul 24, 2025

BioMarin’s BMN 349: A Promising Step in Genetic Lung Condition Treatment - TipRanks

Jul 24, 2025

Jul 24, 2025

What drives BioMarin Pharmaceutical Inc. stock priceFree Predictions - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

What risks could impact BioMarin Pharmaceutical Inc. stock performanceRapid wealth creation - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Will BioMarin Pharmaceutical Inc. stock benefit from AI tech trendsFree Consultation - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET - Eastern Progress

Jul 24, 2025

Jul 23, 2025

BioMarin: Less Likely M&A Target As New Rival For Best-Selling Drug Emerges (Rating Downgrade) - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

BioMarin Pharmaceutical Inc. Stock Analysis and ForecastOutstanding growth strategies - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Investors Still Waiting For A Pull Back In BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - simplywall.st

Jul 22, 2025

Jul 19, 2025

BioMarin Bets On Growth, But Competition Keeps Pressure On - Finimize

Jul 19, 2025

Jul 17, 2025

BioMarin’s BMN 349 Study: A Potential Game-Changer in Genetic Disorder Treatment - TipRanks

Jul 17, 2025

Jul 17, 2025

Morgan Stanley Sees Rebound Potential in BioMarin (BMRN), Highlights Underappreciated Voxzogo Upside - Yahoo

Jul 17, 2025

Jul 16, 2025

Is BioMarin Pharmaceutical (NASDAQ:BMRN) Using Too Much Debt? - 富途牛牛

Jul 16, 2025

Jul 16, 2025

Looking for a Growth Stock? 3 Reasons Why BioMarin (BMRN) is a Solid Choice - Yahoo Finance

Jul 16, 2025

Jul 16, 2025

Wall Street Analysts Think BioMarin (BMRN) Could Surge 70.77%: Read This Before Placing a Bet - Zacks Investment Research

Jul 16, 2025

Jul 15, 2025

BioMarin stock maintains Outperform rating at Wolfe Research amid PKU market competition By Investing.com - Investing.com South Africa

Jul 15, 2025

Jul 15, 2025

BioMarin stock maintains Outperform rating at Wolfe Research amid PKU market competition - Investing.com Nigeria

Jul 15, 2025

Jul 14, 2025

What makes BioMarin Pharmaceutical Inc. stock price move sharplyFree Step-by-Step Investment Guide - beatles.ru

Jul 14, 2025

Jul 14, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - NewsBreak: Local News & Alerts

Jul 14, 2025

Jul 14, 2025

Unpacking Q1 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN) In The Context Of Other Therapeutics Stocks - Yahoo Finance

Jul 14, 2025

Jul 13, 2025

BioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme Pharma - MSN

Jul 13, 2025

Jul 11, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript - MSN

Jul 11, 2025

Jul 11, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - sharewise.com

Jul 11, 2025

Jul 10, 2025

Will BioMarin (BMRN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 10, 2025

Jul 09, 2025

10 Best Growth Stocks to Buy With Huge Upside Potential - Insider Monkey

Jul 09, 2025

Jul 08, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock - Yahoo Finance

Jul 08, 2025

Jul 03, 2025

BioMarin’s BMN 349 Study: A New Frontier in Genetic Mutation Treatment - TipRanks

Jul 03, 2025

Jul 03, 2025

BioMarin stock rating initiated at Overweight by Morgan Stanley on Voxzogo growth - Investing.com

Jul 03, 2025